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Abstract
Introduction It is well established that women with high
mammographic density are at greater risk for breast cancer than
are women with low breast density. However, little research has
been done on mammographic density and ductal carcinoma in
situ (DCIS) of the breast, which is thought to be a precursor
lesion to some invasive breast cancers.
Method We conducted a nested case-control study within the
Multiethnic Cohort, and compared the mammographic densities
of 482 patients with invasive breast cancer and 119 with breast
DCIS cases versus those of 667 cancer-free control subjects. A
reader blinded to disease status performed computer-assisted
density assessment. For women with more than one
mammogram, mean density values were computed. Polytomous
logistic regression models were used to compute adjusted odds
ratios (ORs) and 95% confidence intervals (CIs) for two
measurements of mammographic density: percentage density
and dense area.
Results Mammographic density was associated with invasive
breast cancer and breast DCIS. For the highest category of
percentage breast density (≥50%) as compared with the lowest
(<10%), the OR was 3.58 (95% CI 2.26–5.66) for invasive
breast cancer and 2.86 (1.38–5.94) for breast DCIS. Similarly,
for the highest category of dense area (≥45 cm2) as compared
with the lowest (<15 cm2), the OR was 2.92 (95% CI 2.01–
4.25) for invasive breast cancer and 2.59 (1.39–4.82) for breast
DCIS. Trend tests were significant for invasive breast cancer (P
for trend < 0.0001) and breast DCIS (P for trend < 0.001) for
both percentage density and dense area.
Conclusion The similar strength of association for
mammographic density with breast DCIS and invasive breast
cancer supports the hypothesis that both diseases may have a
common etiology.
Introduction
As a result of increasing early detection efforts, breast carci-
noma in situ (CIS) constitutes more than 20% of newly diag-
nosed breast cancer cases in the USA [1]. Although breast
CIS shares a number of risk factors with invasive breast can-
cer, and ductal carcinoma in situ (DCIS) of the breast is con-
sidered to be a precursor to some invasive breast cancers [2],
it is not clear to what extent breast CIS and invasive breast
cancer have the same etiology. Several case-control studies
have confirmed that mammographic density is associated with
risk for breast cancer [3]; women with high breast density have
a three-fold to six-fold greater risk for developing breast cancer
than women with low breast density [3,4]. Most studies of
mammographic density included only invasive breast cancer
cases [5] or combined invasive and CIS cases [6-10]. One
study investigating breast CIS observed that DCIS was more
likely to occur in mammographically dense areas [11], and
another study reported an increase in breast hyperplasia or
atypia/CIS in women with greater than 50% breast density
[12]. This analysis examines the association between mammo-
graphic density and risk for breast DCIS in comparison with
invasive breast cancer and breast cancer-free control
subjects.
Materials and methods
Study population
The data for this analysis were collected using a nested case-
control study within the Hawaii component of the Multiethnic
Cohort, which was established between 1993 and 1996 [13].
As described in detail elsewhere [4], all female members
BHQ = Breast Health Questionnaire; BMI = body mass index; CI = confidence interval; CIS = carcinoma in situ; DCIS = ductal carcinoma in situ; 
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diagnosed with primary breast cancer between cohort entry
and December 2000 were identified as potential cases (n =
1,587). A similar number of randomly selected control sub-
jects (n = 1,584) who were not known to have breast cancer
were frequency matched to the distribution of ethnicity and 5-
year age groups of the cases. Cases and controls with a pre-
vious diagnosis of breast cancer, a history of breast augmen-
tation or reduction, and no mammogram were excluded.
Approximately 13% of breast cancer cases and 4% of con-
trols were ineligible primarily because of death or pre-existent
breast cancer. Of the 1,396 cases eligible to participate,
52.6% responded to the mailings and gave full consent. Of the
1,500 eligible controls, 48.7% responded to the mailings and
gave full consent. After removing women who did not have
suitable mammograms, the final sample consisted of 607
breast cancer cases and 667 control subjects. The original
cohort and the nested case-control study were approved by
the Committee on Human Studies at the University of Hawaii.
All participants provided informed consent to participate in
both studies.
Data collection
Details of the study procedures were reported previously [4].
In brief, information on demographics, medical history, repro-
ductive behavior, hormone replacement therapy (HRT) use,
and body mass index (BMI) were collected with an extensive
questionnaire at entry into the cohort during the period from
1993 to 1996 [13]. As part of the nested case-control study,
a one-page Breast Health Questionnaire (BHQ) was com-
pleted to elicit information on menopausal status, previous
breast surgery, mammography, and HRT medications [4].
Mammograms
The mammographic films were retrieved from clinics located
throughout the State of Hawaii using the authorization forms
signed by the study participants. The original cohort study had
Table 1
Characteristics of the study population by disease status
Covariate Invasive breast cancer Breast DCIS Controls P valuea
Sample size 482 119 667 -
Ethnicity (%) 0.19b
Hawaiian 14.3 8.4 24.3
Japanese 46.5 55.5 43.8
Caucasian 32.6 28.6 28.0
Other 6.6 7.6 3.9
Age at diagnosis (years) 63.5 62.9 N/A 0.50b
Age at recruitment (years) 60.0 59.6 56.7 0.58b
Mean age at all mammograms (years) 59.8 59.1 59.7 0.70
Body mass index (kg/m2) 25.2 24.5 25.7 0.07
Time from first mammogram to diagnosis (years) 6.2 6.7 N/A 0.17b
Family history of breast cancer (%) 16.8 16.8 12.0 0.05
Age at first birth (years) 25.0 25.1 24.7 0.65
Age at menarche (years) 13.1 12.9 13.1 0.47
Parous (%) 84.5 83.9 88.5 0.10
Number of children 2.4 2.2 2.6 0.02
Postmenopausal (%) 86.3 89.9 77.7 <0.0001
Ever HRT use (%) 67.2 73.9 69.3 0.01
Number of mammograms 3.2c 3.4c 2.4c <0.0001
Breast percent densityd 36.5 38.2 29.4 <0.0001
Breast dense aread (cm2) 36.7 34.9 28.7 <0.0001
Total breast aread (cm2) 114.5 106.9 118.9 0.08
Unless otherwise indicated, mean values are given. aP ascertained from t test or χ2 test, as appropriate. bCompares only invasive breast cancer 
and breast DCIS cases. All other comparisons are of invasive breast cancer cases, breast DCIS cases, and controls. cThe range for number of 
mammograms is 11, 10, and 7 for invasive breast cancer, breast DCIS, and controls, respectively. dAdjusted for age at recruitment. DCIS, ductal 
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no records on mammography use except for one item in the
baseline questionnaire. At that time, 90% of Caucasian and
Japanese women and 75% of Native Hawaiian women
reported previous mammography [14]. Only craniocaudal
views were digitized using a Kodak LS 85 Film Digitizer with a
pixel size of 260 µm. If available, mammograms for every sec-
ond or third year were scanned with the goal being to cover as
wide a time period as possible for each woman. For cases,
only mammograms taken before treatment for breast cancer
were selected. However, the image of the contralateral breast
taken at the time of diagnosis was used for five cases. The
scanned images for both breasts were assessed for densities
using Cumulus108 software [15] by one reader (GM), who
was blinded to case status and time sequence of the mammo-
grams. After the reader determined a threshold for the edge of
the breast and for the edge of the dense tissue [15], the com-
puter calculated the total number of pixels in the digitized
image that constituted the total area and the dense area and
computed the ratio between the two values as percentage
density. Because readings for the right and left breast were
very similar (correlation coefficient >0.90), we averaged the
values for both to obtain one measure of total breast area,
dense area and percentage density.
A random sample of 410 mammograms was read in duplicate
to assess the reliability of the mammographic readings. The
intraclass correlation coefficients [16] were 0.96 (95% confi-
dence interval (CI) 0.95–0.97) for the size of dense area and
0.996 (95% CI 0.995–0.997) for the total breast area, result-
ing in an intraclass correlation coefficient for percentage den-
sity of 0.974 (95% CI 0.968–0.978).
Statistical analysis
To test for differences in covariate values across breast cancer
cases and control subjects, we performed t tests for continu-
ous variables and χ2 tests for categorical variables. We used
unconditional polytomous logistic regression modeling with
the SAS software [17] to compute odds ratios (ORs) and
95% CIs for the risks for DCIS and invasive cancer associated
with breast density [18]. All P values reported are two sided.
Breast cancer cases were divided into CIS and invasive based
on information provided by the state-wide Hawaii Tumor Reg-
istry, a member of the National Cancer Institute's Surveillance,
Epidemiology and End Results program. Of the 125 breast
CIS cases, 119 were classified as having DCIS.
We chose two measures of mammographic breast density as
our exposure variables: size of the dense area and percentage
density. Percentage density was grouped into four commonly
used categories: <10%, 10–24.9%, 25–49.9%, and ≥50%.
The size of the dense areas was classified as follows: <15
cm2, 15–29.9 cm2, 30.0–44.9 cm2, and ≥45 cm2. Study par-
ticipants were grouped into four categories: Japanese, Cauca-
sians, native Hawaiians and others (mostly Filipinos). To
maximize the number of participants per group, women of
mixed ancestry – regardless of admixture – were assigned to
one ethnic category according to the following priority ranking:
native Hawaiian, Japanese, Caucasian, and, finally, other [13].
We created an HRT variable using the responses from the
questionnaire at cohort entry and from the BHQ at enrollment
into the breast density study. A comparison of the HRT infor-
mation from the two questionnaires exhibited good agreement
for overlapping years when both questionnaires reported HRT
use. If a woman indicated that she had used HRT at any time
but the write-in field in the BHQ was empty, we assigned the
type of HRT from the cohort questionnaire completed at base-
line. For the women with missing HRT type information (5.4%),
we imputed the type based on hysterectomy status: estrogen
only for women with a hysterectomy and combined therapy
otherwise.
All models were adjusted for the following covariates that are
known to be associated with breast cancer and mammo-
graphic density: mean age of all mammograms (continuous),
ethnicity, BMI (<22.5, 22.5 to <25, 25 to <30, or ≥30 kg/m2),
parity (0–1, 2–3, or ≥4), age at menarche (<13, 13–14, or ≥15
years), age at first live birth (<21, 21–30, >30 years, or no chil-
dren), menopausal status (pre- or postmenopausal), family his-
tory of breast cancer (breast cancer in a first-degree relative or
no history), and HRT use (never, estrogen only, or estrogen +
progestin). Tests for trend were performed by fitting a variable
representing ordinal categories (described above) of percent-
age density or dense area.
We were also interested in comparing how well percentage
breast density and size of dense area predicted invasive
breast cancer and breast DCIS. We performed unconditional
binary logistic regression and examined the area under the
receiver operating characteristic (ROC) curve, which is a
method used in sensitivity-specificity analyses. The ROC
curve assesses the ability of the model to distinguish between
two groups (for example, diseased and disease free). If the
model is able to separate the two groups perfectly, then the
area under the ROC curve is equal to 1; if the model performs
no better than chance, then the area will be 0.5.
Results
Of all breast cancer cases, 119 (19.8%) were breast DCIS
(Table 1). Japanese women had a greater proportion of breast
DCIS than invasive breast cancer, and native Hawaiian women
had almost twice the proportion of invasive cases compared
with DCIS cases (P = 0.19). The mean age at diagnosis was
similar for breast DCIS and invasive cases (P = 0.50). How-
ever, the breast DCIS cases had a greater proportion of post-
menopausal women (89.9% versus 86.3% and 77.7% (for
DCIS, invasive cases, and controls, respectively)) and had
fewer children (2.2 versus 2.4 and 2.6 (for DCIS, invasive
cases and controls, respectively)). Women with invasive
breast cancer or breast DCIS had more mammograms than
did controls (P < 0.0001). However, mean unadjusted age atBreast Cancer Research    Vol 8 No 3    Gill et al.
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first mammogram and last mammogram were not different
across breast DCIS cases, invasive breast cancer cases, and
controls (P = 0.32 and P = 0.66, respectively; results not
shown). Although invasive breast cancer cases had a greater
age-adjusted mean dense breast area than did breast DCIS
cases (36.7 cm2 and 34.9 cm2, respectively), the breast DCIS
cases had higher percentage breast densities (38.2% and
36.5%, respectively) than did the invasive breast cancer cases
because of their smaller mean total breast area.
Both percentage density and the size of the dense area were
associated with breast DCIS and invasive breast cancer in our
study (Table 2). For each cancer, trend tests were highly sig-
nificant. Women with at least 50% percentage density had a
3.5-fold greater risk for invasive breast cancer than women
with less than 10% density (OR 3.58, 95% CI 2.26–5.66)
when compared with controls. The risk for DCIS was almost
threefold greater in women with 50% or more percentage den-
sity than in women with less than 10% density (OR 2.86, 95%
CI 1.38–5.94). For breast DCIS, the 95% CIs for the second
and third categories of density included the null value. The
comparison of breast DCIS with invasive breast cancer indi-
cated a lower, although not statistically significant, risk for
breast DCIS than for invasive cancer given the same level of
percentage density. The risk estimates for the size of dense
area in the breast were not as strong as they were for percent-
age breast density. For women with more than 45 cm2 of
dense breast area, the ORs of invasive breast cancer and
breast DCIS were 2.92 (95% CI 2.01–4.25) and 2.86 (95%
CI 1.57–5.20), respectively, compared with controls. The
comparison of breast DCIS versus invasive breast cancer
cases showed little difference.
Because of sample size limitations, we were only able to ana-
lyze mammographic density and risk for breast DCIS by eth-
nicity for Japanese and Caucasian women (results not shown).
Both ethnic groups exhibited similar trends; risk for breast
DCIS increased with increasing percentage density and
dense area. However, the CIs were wide and, except for the
highest category of percentage density and dense area in
Caucasian women, all intervals included 1.
The area under the ROC curve was similar for percentage
density and dense area. For the adjusted invasive breast can-
cer model, both values were 0.74, whereas for the adjusted
breast DCIS model the areas under the ROC curve were 0.67.
When modeled without adjustment for covariates, the area
under the ROC curve for invasive breast cancer was 0.59 for
both percentage density and dense area. A similar unadjusted
model for DCIS yielded values of 0.59 for dense area and 0.61
for percentage density.
Discussion
Our analyses revealed that mammographic breast density, as
measured by percentage density and the size of dense area, is
associated with breast DCIS as well as invasive breast cancer.
The association was slightly weaker for breast DCIS than for
invasive breast cancer. Comparisons of areas under the ROC
curve indicated that breast density and dense area performed
equally well in distinguishing breast DCIS and invasive breast
cancer cases from controls. The ORs for breast DCIS in the
present study were not as large as those reported in a study
of a cohort of Canadian women [12], which estimated relative
risks between 7 and 12 for detecting atypia/CIS in biopsy
specimens from women with more than 50% density. How-
ever, the cell sizes within the strata of density were small in that
Table 2
Mammographic breast density and risk estimates for breast DCIS and invasive breast cancer
Exposure variable Invasive breast cancer (n)B r e a s t  D C I S  ( n) Controls (n) Invasive versus controls DCIS versus controls DCIS versus invasive
Mean percentage density (%)
<10 63 18 158 1 (reference) 1 (reference) 1 (reference)
10–24.9 110 23 170 1.81 (1.21–2.70) 1.15 (0.57–2.30) 0.65 (0.31–1.35)
25–49.9 174 34 212 2.53 (1.69–3.78) 1.29 (0.64–2.59) 0.56 (0.27–1.17)
≥50 135 44 127 3.58 (2.26–5.66) 2.86 (1.38–5.94) 0.89 (0.41–1.91)
P value for trend <0.0001 0.0010
Mean breast dense area (cm2)
<15 95 26 209 1 (reference) 1 (reference) 1 (reference)
15–29.9 136 29 200 1.58 (1.12–2.23) 1.05 (0.58–1.92) 0.75 (0.40–1.40)
30–44.9 109 28 133 1.93 (1.32–2.81) 1.70 (0.90–3.22) 0.92 (0.48–1.76)
≥45 142 36 125 2.92 (2.01–4.25) 2.59 (1.39–4.82) 0.99 (0.53–1.86)
P value for trend <0.0001 0.0026
Values are expressed as odds ratios (95% confidence intervals), which were estimated using polytomous logistic regression and adjusted for 
ethnicity, mean age of all mammograms, body mass index, age at first live birth, number of children, age at menarche, menopausal status, use of 
hormone replacement therapy, and family history of breast cancer. DCIS, ductal carcinoma in situ.Available online http://breast-cancer-research.com/content/8/3/R30
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study and cases were selected from a group of women with
biopsies. A British case-control study [19] found much lower
risks for breast CIS, and the estimates were similar in strength
to those for invasive breast cancer. Women with Wolfe paren-
chymal patterns P2 or DY had 70% greater risk (95% CI 1.1–
2.6) of screening detected in situ breast cancer compared
with controls and a 30% greater risk (95% CI 1.2–1.8) of
screening detected invasive breast cancer compared with
controls.
Other studies of breast DCIS support the idea that there is a
relation between in situ lesions and mammographic density.
An investigation of 28 mammograms confirmed that breast
DCIS occurs to a greater extent in areas of the breast that
exhibit high mammographic density [11]. The relative risk for a
second breast cancer was found to be three times higher
among women with primary DCIS who had mammographic
densities of 75% and greater compared with women with less
than 25% density [20].
Although it is known that some breast DCIS lesions will
develop into invasive breast cancers [21], and that DCIS is
often found near invasive breast cancer lesions [22], it remains
problematic to distinguish DCIS lesions that may progress to
invasive breast cancer from those that may not. Given the
growing number of breast CIS cases with increasing mam-
mography screening [1], this question has important implica-
tions when decisions must be made regarding the
aggressiveness of treatment [23]. A comparison of risk factors
for CIS (ductal and/or lobular) and invasive breast cancer
found mixed results. Established invasive breast cancer risk
factors shown to be consistently associated with breast CIS
include family history of breast cancer [24-30], low BMI
among premenopausal women [24,29,30], and nulliparity
[24,28,30,31]. However, other invasive breast cancer risk fac-
tors such as early age at menarche, late age at menopause,
increased endogenous estrogen levels, and alcohol intake
were associated with breast CIS in some studies
[26,27,29,32], but not in others [24-27,30,33].
Our study and other reports mentioned above indicate that
mammographic density is associated with breast CIS and with
invasive breast cancer. However, because some studies
describe differential effects for some risk factors, more
research needs to be done. Studies with larger samples of
breast CIS must be performed to assess whether factors such
as postmenopausal obesity, growth factors (insulin-like growth
factor-I), exogenous hormones, and cell proliferation biomark-
ers can help in elucidating the association between breast
density, breast CIS, and progression to invasive breast cancer.
New molecular techniques may have the ability to identify fac-
tors that are responsible for the progression from DCIS to
invasive cancer [2].
A limitation of the present study is the lack of data on the fre-
quency of mammography use. Although this population has
high screening rates [14], we cannot rule out bias toward the
null in estimates of DCIS risk because of the possibility of
undetected breast DCIS among controls. We also had rela-
tively low participation rates, although a comparison of partic-
ipating and eligible women revealed that they had very similar
characteristics [4]. Our assessments of HRT and BMI are lim-
ited because we had to rely on self-report, and assumed that
their values remained constant between the time they were
reported and when the study was completed, but an examina-
tion of BMI from a follow-up questionnaire five years after
cohort entry showed that the mean BMI changes by only 0.50
kg/m2  during that time. Therefore, differences in BMI are
unlikely to change the results materially. The use of BMI in cat-
egories is unlikely to have confounded our results because
analyses with continuous values of BMI gave nearly identical
results. We had limited power to estimate the risk for DCIS;
there were nearly four times as many invasive breast cancer
cases as breast DCIS cases. Nevertheless, the cohort design,
the multiple mammograms, and the frequent mammography
use in this population must be considered strengths of this
project. The high rate of mammography participation
decreases the probability that a large number of cancers were
missed in this population.
Conclusion
In the present study similar patterns of association for mammo-
graphic density with DCIS and invasive breast cancers add to
the growing body of evidence that certain breast CIS and inva-
sive breast cancers may share etiologic factors. At the same
time, it appears likely that factors that have not yet been iden-
tified may influence the effects of breast density and other
known breast cancer risk factors in the progression of breast
CIS to invasive breast cancer.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JG carried out the main statistical analysis, created variables
used in this analysis, and drafted the manuscript. GM con-
ceived of the nested case-control study, performed the mam-
mographic density assessment, and helped with the draft and
revisions of the manuscript. IP created a data set and variables
used in analysis, assisted in writing of SAS programs, and
advised on statistical analysis techniques. LK conceived of the
Multiethnic Cohort and helped in revision of the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The case-control study was funded by a grant from the National Cancer 
Institute (R01 CA 85265). The Multiethnic Cohort Study has been sup-
ported by USPHS (National Cancer Insitute) grant R37 CA 54281. Dr 
Gill was supported by R25 CA 90956. We are very grateful to Jihae Noh 
for her outstanding work in mammogram retrieval and scanning, to Breast Cancer Research    Vol 8 No 3    Gill et al.
Page 6 of 6
(page number not for citation purposes)
Andrew Williams for the excellent database, and to Maj Earle for provid-
ing information from the Multiethnic Cohort Study.
References
1. American Cancer Society SR2: Cancer Facts and Figures 2005
Atlanta, GA: American Cancer Society, Inc.; 2005. 
2. Bernstein L: The epidemiology of breast carcinoma in situ.  In
Ductal Carcinoma In Situ of the Breast 2nd edition. Edited by: Sil-
verstein MJ, Recht A, Lagios MD. Philadelphia: Lippincott, Williams
and Wilkins; 2002. 
3. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Pater-
son AD: Mammographic breast density as an intermediate
phenotype for breast cancer.  Lancet Oncol 2005, 6:798-808.
4. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Mam-
mographic density and breast cancer risk: the Multiethnic
Cohort.  Am J Epidemiol 2005, 162:743-752.
5. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astra-
han M, Siozon CC, Pike MC: Mammographic density and breast
cancer in three ethnic groups.  Cancer Epidemiol Biomarkers
Prev 2003, 12:332-338.
6. Torres-Mejia G, De Stavola B, Allen DS, Perez-Gavilan JJ, Ferreira
JM, Fentiman IS, Dos Santos Silva I: Mammographic features
and subsequent risk of breast cancer: a comparison of quali-
tative and quantitative evaluations in the Guernsey prospec-
tive studies.  Cancer Epidemiol Biomarkers Prev 2005,
14:1052-1059.
7. Maskarinec G, Meng L: A case-control study of mammographic
densities in Hawaii.  Breast Cancer Res Treat 2000, 63:153-161.
8. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA,
Hoover R, Haile R: Mammographic features and breast cancer
risk: effects with time, age, and menopause status.  J Natl Can-
cer Inst 1995, 87:1622-1629.
9. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lock-
wood GA, Tritchler DL, Yaffe MJ: Quantitative classification of
mammographic densities and breast cancer risk: results from
the Canadian National Breast Screening Study.  J Natl Cancer
Inst 1995, 87:670-675.
10. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M,
Wolfe JN: Mammographic densities and risk of breast cancer.
Cancer 1991, 67:2833-2838.
11. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH:
Greatly increased occurrence of breast cancers in areas of
mammographically dense tissue.  Breast Cancer Res 2005,
7:R605-R608.
12. Boyd NF, Jensen HM, Cooke G, Lee Han H: Relationship
between mammographic and histological risk factors for
breast cancer.  J Natl Cancer Inst 1992, 15:1170-1179.
13. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR,
Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS: A Mul-
tiethnic Cohort in Hawaii and Los Angeles: baseline
characteristics.  Am J Epidemiol 2000, 151:346-357.
14. Hawaii State Department of Health: Hawaii Behavioral Risk Factor
Surveillance Report 1994–2000 Honolulu: State of Hawaii; 2002. 
15. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative
analysis of mammographic densities.  Phys Med Biol 1994,
39:1629-1638.
16. Shrout P, Fleiss J: Intraclass correlations: uses in assessing
rater reliability.  Psychol Bull 1979, 86:420-428.
17. SAS Institute Inc: SAS OnlineDoc 9.1.2 Cary, NC: SAS Institute
Inc; 2004. 
18. Hosmer DW, Lemeshow S: Applied Logistic Regression 2nd edi-
tion. New York: John Wiley & SOns Inc; 2000. 
19. Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N:
Size, node status and grade of breast tumours: association
with mammographic parenchymal patterns.  Eur Radiol 2000,
10:157-161.
20. Habel LA, Dignam JJ, Land SR, Salane M, Capra AM, Julian TB:
Mammographic density and breast cancer after ductal carci-
noma in situ.  J Natl Cancer Inst 2004, 96:1467-1472.
21. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA: Con-
tinued local recurrence of carcinoma 15–25 years after a diag-
nosis of low grade ductal carcinoma in situ of the breast
treated only by biopsy.  Cancer 1995, 76:1197-1200.
22. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC: Inci-
dence of and treatment for ductal carcinoma in situ of the
breast.  JAMA 1996, 275:913-918.
23. Leonard GD, Swain SM: Ductal carcinoma in situ, complexities
and challenges.  J Natl Cancer Inst 2004, 96:906-920.
24. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V: Compar-
ison of risk factors for ductal carcinoma in situ and invasive
breast cancer.  J Natl Cancer Inst 1997, 89:76-82.
25. Gapstur SM, Morrow M, Sellers TA: Hormone replacement ther-
apy and risk of breast cancer with a favorable histology:
results of the Iowa Women's Health Study.  JAMA 1999,
281:2091-2097.
26. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL: Risk
factors for carcinoma in situ of the breast.  Cancer Epidemiol
Biomarkers Prev 2000, 9:697-703.
27. Claus EB, Stowe M, Carter D: Breast carcinoma in situ: risk fac-
tors and screening patterns.  J Natl Cancer Inst 2001,
93:1811-1817.
28. Brinton LA, Hoover R, Fraumeni JF Jr: Epidemiology of minimal
breast cancer.  JAMA 1983, 249:483-487.
29. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK:
Risk factors for in situ breast cancer.  Cancer Epidemiol Biomar-
kers Prev 1996, 5:961-965.
30. Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD,
Malone KE, Schoenberg JB, Swanson CA: Epidemiology of in
situ and invasive breast cancer in women aged under 45.  Br J
Cancer 1996, 73:1298-1305.
31. Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami
HO: Parity, age at first birth and the risk of carcinoma in situ of
the breast.  Int J Cancer 1998, 77:330-332.
32. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE: Endog-
enous estrogen, androgen, and progesterone concentrations
and breast cancer risk among postmenopausal women.  J Natl
Cancer Inst 2004, 96:1856-1865.
33. Zeleniuch-Jacquotte A, Gu Y, Shore RE, Koenig KL, Arslan AA,
Kato I, Rinaldi S, Kaaks R, Toniolo P: Postmenopausal levels of
sex hormones and risk of breast carcinoma in situ: results of
a prospective study.  Int J Cancer 2005, 114:323-327.